Clinical outcomes according to the average daily dose of sacubitril/valsartan: a nationwide longitudinal cohort study
No significant difference was observed in the composite risk of HF hospitalization and all-cause mortality across different sacubitril/valsartan dosage groups. This suggests that the benefits of sacubitril/valsartan treatment may not necessarily be dose-dependent.
Authors
- Kyungdo Han (ORCID: https://orcid.org/0000-0002-6096-1263)
- Jun‐Bean Park (ORCID: https://orcid.org/0000-0003-4053-8713)
- Bong‐Seong Kim (ORCID: https://orcid.org/0000-0002-3562-3916)
- Jaehyun Lim (ORCID: https://orcid.org/0000-0002-9450-5653)
- Soongu Kwak (ORCID: https://orcid.org/0000-0002-1798-7441)
- Heesun Lee (ORCID: https://orcid.org/0000-0003-4037-3955)
- Hyun‐Jung Lee (ORCID: https://orcid.org/0000-0002-7498-0705)
- Hyung‐Kwan Kim (ORCID: https://orcid.org/0000-0001-7950-2131)
- Yong-Jin Kim (ORCID: https://orcid.org/0000-0002-3055-9943)
Institutions
- Seoul National University (KR)
- Soongsil University (KR)
- Yonsei University (KR)
- Severance Hospital (KR)
- New Generation University College (ET)
- Seoul National University Hospital (KR)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1007/s00392-025-02602-x
- Citations
- 1
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Seoul National University